Characterization of passive permeability at the blood–tumor barrier in five preclinical models of brain metastases of breast cancer
- 5 March 2016
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 33 (4) , 373-383
Abstract
The blood–brain barrier (BBB) is compromised in brain metastases, allowing for enhanced drug permeation into brain. The extent and heterogeneity of BBB permeability in metastatic lesions is important when considering the administration of chemotherapeutics. Since permeability characteristics have been described in limited experimental models of brain metastases, we sought to define these changes in five brain-tropic breast cancer cell lines: MDA-MB-231BR (triple negative), MDA-MB-231BR-HER2, JIMT-1-BR3, 4T1-BR5 (murine), and SUM190 (inflammatory HER2 expressing). Permeability was assessed using quantitative autoradiography and fluorescence microscopy by co-administration of the tracers 14C-aminoisobutyric acid (AIB) and Texas red conjugated dextran prior to euthanasia. Each experimental brain metastases model produced variably increased permeability to both tracers; additionally, the magnitude of heterogeneity was different among each model with the highest ranges observed in the SUM190 (up to 45-fold increase in AIB) and MDA-MB-231BR-HER2 (up to 33-fold in AIB) models while the lowest range was observed in the JIMT-1-BR3 (up to 5.5-fold in AIB) model. There was no strong correlation observed between lesion size and permeability in any of these preclinical models of brain metastases. Interestingly, the experimental models resulting in smaller mean metastases size resulted in shorter median survival while models producing larger lesions had longer median survival. These findings strengthen the evidence of heterogeneity in brain metastases of breast cancer by utilizing five unique experimental models and simultaneously emphasize the challenges of chemotherapeutic approaches to treat brain metastases.Keywords
Funding Information
- National Institute of General Medical Sciences (GM103434, P30GM103488, U54GM104942)
- National Cancer Institute (R01CA166067)
This publication has 56 references indexed in Scilit:
- Novel insights into the development and maintenance of the blood–brain barrierCell and tissue research, 2014
- Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implicationsJournal of Molecular Medicine, 2013
- Molecular characterisation of cell line models for triple-negative breast cancersBMC Genomics, 2012
- Advances in imaging low-grade gliomas2010
- Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability studyBrain Research, 2006
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study.The Journal of Physiology, 1990
- Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetrationCancer Chemotherapy and Pharmacology, 1990
- Vascular structures in brain tumorsHuman Pathology, 1975
- Breast Tumor Cell Lines From Pleural Effusions2JNCI: Journal of the National Cancer Institute, 1974